Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma

ECHELON-1 Study Group, Murali Janakiram

Research output: Contribution to journalArticlepeer-review

539 Scopus citations

Fingerprint

Dive into the research topics of 'Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry